Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Carboplatin and Paclitaxel in Metastatic Melanoma
NCT00434252Phase 2Completed
- Sponsor
- Genentech
- Start
- Feb 2007
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in melanoma, sponsored by Genentech. Started Feb 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00434252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434252.